MedTrace Logo

Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)

NCT01592955 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2015-06-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness and the safety of the cyclocoagulation using High Intensity Focused Ulatrsound with the EYEOP1 device in glaucoma patients

Conditions

Interventions

DEVICE

EYEOP1

Cyclocoagulation using High Intensity Focused Ultrasound with EYEOP1 device

Sponsors & Collaborators

  • EyeTechCare

    lead INDUSTRY

Principal Investigators

  • Laurent FARCY · EyeTechCare

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-03-31
Completion
2015-03-31

Countries

  • Israel
  • Italy
  • Spain
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01592955 on ClinicalTrials.gov